In relation to the cost involved in changing form non-heat-treated to heat-treated material in the northern region, there was an argument as to whether people who were HIV antibody positive should continue to receive contaminated material.

Chronology Information

Date:

Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation